Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel
NCT03895281 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2019-03-29
Summary
The FilmArray Meningitis/Encephalitis (ME) Panel (hereinafter referred to as FilmArray ME Panel) is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with FilmArray systems. The FilmArray ME Panel is capable of simultaneous detection and identification of multiple bacterial, viral, and yeast nucleic acids directly from cerebrospinal fluid (CSF) specimens obtained via lumbar puncture from individuals with signs and/or symptoms of meningitis and/or encephalitis.
Conditions
- Meningitis/Encephalitis
Interventions
- DIAGNOSTIC_TEST
-
FilmArray Meningitis/Encephalitis (ME) Panel
The FilmArray ME pouch is a closed system disposable that houses all the chemistry required to isolate, amplify and detect nucleic acid from multiple meningitis and encephalitis pathogens within a single CSF specimen obtained from a lumbar puncture. The rigid plastic component (fitment) of the FilmArray ME pouch contains reagents in freeze-dried form. The flexible plastic portion of the pouch is divided into discrete segments (blisters) where the required chemical processes are carried out. The user of the FilmArray ME Panel loads the sample into the FilmArray ME pouch, places the pouch into the FilmArray instrument/Module, and starts the run. All other operations are automated.
Sponsors & Collaborators
-
BioMérieux
collaborator INDUSTRY -
Shanghai Children's Medical Center
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2019-12-31
- Completion
- 2020-04-30
More Related Trials
-
Host Response to Infection and Treatment in Lymphatic Filarial Disease in India
NCT00342576 ·Status: COMPLETED
-
Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV
NCT05385510 ·Status: COMPLETED ·Phase: PHASE1
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
NCT04003532 ·Status: COMPLETED
-
A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants
NCT02083887 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
NCT00431808 ·Status: UNKNOWN ·Phase: PHASE1
-
An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP
NCT03707353 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration
NCT03084289 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP
NCT06881732 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5
NCT02181088 ·Status: COMPLETED ·Phase: PHASE1
-
A Systems Biology Approach to Malaria Immunity
NCT03014258 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of RealAmp Method for the Diagnosis of Malaria in Endemic Areas of Brazil
NCT02371395 ·Status: COMPLETED
-
Malaria Clinical Trials Center General Screening
NCT02119312 ·Status: COMPLETED
-
The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
NCT02533336 ·Status: TERMINATED ·Phase: PHASE3
-
An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
NCT06089668 ·Status: COMPLETED
-
Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires
NCT01214876 ·Status: COMPLETED
-
Covid-19 Vaccine Response in Immunocompromised Haematology Patients
NCT04805216 ·Status: COMPLETED
-
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen
NCT00408668 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
R21/Matrix-M in African Children Against Clinical Malaria
NCT04704830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies
NCT05148806 ·Status: COMPLETED
-
Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
NCT05105035 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
NCT06997159 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909
NCT01351948 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.
NCT05812586 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313
NCT02532049 ·Status: COMPLETED ·Phase: PHASE1